It is well known that medicine is a special commodity that can meet people’s needs for treatment and rescue. However, pharmaceutical preparations involve a lot of content in the process of research and development. In drug development, it may be affected by such things as low level of drug development, more repetitive drugs, and drug development. Due to factors such as the need to increase the types and insufficient investment funds of enterprises, the outsourcing of preparation process will help promote the research and development of drugs. There are many factors involved in the development of pharmaceutical preparations, among which the selection and determination of excipients is an important factor.
Medicilon provides R&D and production services for pharmaceutical preparations. According to the characteristics of the dosage form, combined with the physical and chemical properties and stability of the drug, the production conditions and equipment are considered, process research is carried out, the preparation process of laboratory samples is initially determined, and the corresponding Process control indicators.
The quality of the drug is not only related to the raw material drug, but also closely related to the excipients. The excipients should be “inert substances”, stable in nature, not react with the main drug, and have no physiological activity, do not affect the determination of the content of the main drug, and have a good effect on the dissolution and dissolution of the drug. No adverse effects on absorption. At present, the domestic management of excipients used for medicine has also been strengthened, the quality of them has been supervised, and relevant standards have been formulated at the same time. The outsourcing of the preparation process needs to analyze the raw and auxiliary materials in the preparation process to determine whether the raw materials and auxiliary materials are available. If necessary, a compatibility test of the raw and auxiliary materials is also required.
(1) Researchers should consider and use auxiliary materials that can improve the solubility of drugs with low solubility when conducting research on the formulation design. If the drug has poor stability, you should consider choosing a metal ion complexing agent to moderate the amount.
(2) For the design of chemical drug formulations, it is required to simplify the prescription design plan as much as possible on the premise that the efficacy of the drug is guaranteed, not only to avoid waste in the use of materials, but also to prevent the introduction of auxiliary materials Destroy the efficacy of the drug, or cause unpredictable effects on the drug’s effect.
When screening and researching new chemical structure drugs, attention should be paid to the investigation of the interaction between the main drug and the excipients. The compatibility test of the raw and excipients is very important in the development of the formulation. Medicilon provides preparation process outsourcing services, which can consider production conditions and equipment in accordance with the characteristics of the dosage form, combined with the physical and chemical properties and stability of the drug, conduct process research, initially determine the preparation process of laboratory samples, and establish the corresponding process Control indicators.
Compatibility test of raw materials and excipients is one of the important service contents of preparation process outsourcing agencies, which can provide effective data for the selection and determination of preparation excipients and preparation process. The properties of the auxiliary materials and various external factors may affect the compatibility of the raw materials and auxiliary materials. To investigate whether the raw materials and excipients are compatible, generally a small amount of the mixture can be taken to determine the stability of the drug formulation under high temperature, high humidity, and strong light conditions. The properties of the drug can be analyzed in different combinations to determine whether the drug has changed.
If the conditions are active, the original and excipients can be separated for parallel control experiments to determine the root cause of the change in drug properties. If you do not understand the relevance of the raw materials at all before conducting the preparation experiment, or if the stability of the raw materials is found to be poor through relevant data verification, even if the formulation of the pharmaceutical preparation and the raw and auxiliary materials are the same as the original prescription, then the raw and auxiliary materials are compatible The inspection cannot be ignored. Because the selected manufacturer cannot guarantee the same, the slight difference in the ratio will also cause the difference in the shape and so on.
When testing the compatibility of raw materials and auxiliary materials, it is necessary to make full use of limited research information to ensure that the selected raw materials are stable. Generally speaking, there are not too many requirements for the various qualities of auxiliary materials. When the prescription of the original drug can be searched by a series of methods, and the excipients selected for production and experiment are completely consistent with the prescription, model, and manufacturer of the original drug, the compatibility of raw materials and excipients can be completely checked.
If the excipients used are not exactly the same as the prescription of the original drug, or if other excipients are added on the basis of the original excipients, the compatibility of the raw materials and excipients cannot be neglected. Of course, sometimes the compatibility test of excipients can also be used to make the test simple. The specific operation steps can be guided by drug stability.
Analysis on the Composition and Preparation Process of Oral Solid Dosage Forms
Dosage Research and Common Dosage Forms
The Spray Drying Method of Solid Dispersant Preparation Technology
Method for checking the water content in the development of solid dosage forms
Relevant
news
marketing@medicilon.com
